INTEGRA Biosciences, is dedicated to accelerating scientific discovery while addressing climate change.

Companies form expert working group to introduce essential tools for AAV development and research professionals.

Just – Evotec Biologics will deliver an ultra-rapid, cost-efficient biotherapeutics manufacturing platform solution for the DOD’s Manufacturing Optimization Program.

Four new anti-idiotypic antibodies and a new anti-MMAE antibody range support bioanalytical assay development for preclinical research and clinical trials.

Compact design integrates Type 1 water purification with a flexible dispensing unit. Choice of four models tailored to different feed water sources and applications.

Biotech Fluidics reports on the successful development and implementation of a pioneering combined micro flowmeter and degasser set-up to improve dispensing of a nanoparticulate formulation for a leading medical technology company.

circVec 2.1 DNA vectors have now demonstrated higher and more durable expression vs. conventional mRNA-based expression in vivo for up to five months.

Ready-to-use kit enables detection of binding antibodies against AAV vectors without the need for serotype-specific assays.

SGD Pharma has published its latest 2023 Corporate Social Responsibility (CSR) Report illustrating the sustainable practices deeply embedded in its business ethos.

The Cell and Gene Therapy Catapult (CGT Catapult), and Plurify have received over £340,000 funding from Innovate UK as part of the Transforming Medicines Manufacturing Programme.